Vanguard International ETF Face-Off: VXUS vs. VWO
VXUS delivered 20.1% returns over one year while maintaining lower costs, but VWO's emerging-market focus offers distinct growth potential for risk-tolerant investors.
Search fresh public links, source activity, and ready-to-use post angles for Vxus.
Fresh curated links around VXUS are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
VXUS delivered 20.1% returns over one year while maintaining lower costs, but VWO's emerging-market focus offers distinct growth potential for risk-tolerant investors.
VT includes U.S. equities with a 30% tech weighting, while IXUS focuses on non-U.S. markets and offers a 3.0% dividend yield for income investors.
International stock ETFs offer superior diversification, lower valuations, and higher yields than S&P 500 ETFs like VOO.
VXUS offers broader diversification with 8,600+ holdings and lower costs, while NZAC targets climate-aligned companies with concentrated tech exposure.
IEFA delivered $1,555 on a $1,000 five-year investment versus VWO's $1,416, though VWO charges a marginally lower 0.06% expense ratio.
XLV's 0.08% expense ratio and 22.7% 1-year return outpace IXJ's global reach, but international diversification comes at a cost.
Vanguard offers broad global exposure, while iShares focuses strictly on developed markets outside of North America. Here's how the two compare.
VGSH delivers stronger returns and lower volatility, while VTES offers federal tax-exempt income for high-earners.
VCSH offers a 4.6% yield and lower expense ratio, while VTES provides federally tax-free income for conservative investors seeking stable returns.
Both charge 0.03% in fees, but SPDW yields 3% while VEA offers nearly 3,900 holdings for broader diversification.
Vanguard's broader healthcare portfolio charges less and yields more, but State Street's pharma-focused fund has delivered stronger recent gains despite higher volatility.
XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.
URTH's 0.24% expense ratio trails EEM's 0.72%, but EEM delivered 29.2% returns over one year versus URTH's 15.6%.
SPGM has delivered slightly higher one- and five-year returns, while VT offers lower costs and deeper diversification.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.